Section Arrow
Quote
ELOX.NASDAQ
- Eloxx Pharmaceuticals Inc
Quotes are at least 15-min delayed:2026/11/04 13:18 EST
Regular Hours
Last
 12.725
-0.195 (-1.51%)
Day High 
13.305 
Prev. Close
12.92 
1-M High
16.81 
Volume 
4.30K 
Bid
12.71
Ask
12.86
Day Low
12.7 
Open
13.305 
1-M Low
12 
Market Cap 
52.15M 
Currency 美元 
P/E 3.67 
%Yield -- 
10-SMA 13.13 
20-SMA 13.32 
50-SMA 15.04 
52-W High 23.3999 
52-W Low 0.000011 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.52/-8.04
Enterprise Value
52.15M
Balance Sheet
Book Value Per Share
11.50
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CRISCuris Inc.1.2499+0.536+75.08%0.2PE
KPTIKaryopharm Therapeutics Inc.0.09+0.0017+1.93%-- 
GERNGeron Corp1.035+0.105+11.29%-- 
INOInovio Pharmaceuticals1.73+0.07+4.22%-- 
RXRXRecursion Pharmaceuticals3.89+0.21+5.71%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.